Skip to Main Content
Search
Home
Cancer Statistics
Accessing Datasets & Tools
Publications
Information for Cancer Registrars
Cancer Statistics
Types of Statistics
Cancer Fact Sheets
Cancer Statistics Review
Fast Stats
Cancer Query Systems
State Cancer Profiles
Cancer Mortality Maps & Graphs
Glossary of Statistical Terms
Glossary of Statistical Terms
Browse by letter:
A
B
C
D
E
F G H
I
J
K
L
M
N O
P
Q
R
S
T U V W X Y Z
or select from list:
AgeAdjusted Rate
Ageconditional Risk
Agespecific rate
Annual Percent Change (APC)
Cancer Burden
Collaborative Staging Algorithm
Confidence Interval
Crude Probability of Death
Crude Rate
Death rate
Delayadjusted Incidence
Delayed Reporting
Extent of Disease
ICCC Classification
In situ cancer
Incidence
Incidence Rate
Invasive Cancer
Joinpoint
Lifetime Risk
Malignant Cancer
Median Age at Diagnosis/Death
Mortality
Prevalence, Complete
Prevalence, Limited Duration
Primary Tumor
Probability
Probability of Developing Cancer
Probability of Dying of Cancer
Reporting Delay
SEER
SEER Registries
Stage
Stage at Diagnosis
Standard Million Population
Standard Population
Statistically Significant
Surveillance Data (Cancer)
Survival
Survival, Causespecific
Survival, Net
Survival, Observed
Survival, Period
Survival, Relative
PDF version
AgeAdjusted Rate
A statistical method allowing comparisons of populations that takes into account agedistribution differences between populations. Most incidence and death data in SEER are ageadjusted, although some tables, in contrast, present the
crude rate
. Ageadjusting takes the 2000 US population distribution and applies it to other time periods under consideration. This assures that such rates do not reflect any changes in the population age distribution. Rates can be adjusted for the distribution of other characteristics such as race/ethnicity
Most data in SEER have been ageadjusted to the 2000 US standard population. This allows comparison across racial groups taking into account differences in age structure of the populations. For example, the average age of many Hispanic/Latino populations is less than that of other racial/ethnic groups. Therefore, it sometimes appears that these groups have lower cancer incidence rates than other groups. However, by adjusting for age, more accurate comparisons can be made. See
Calculating Ageadjusted Rates
for further information
Return to top
Ageconditional Risk
A term related to
lifetime risk
. The probability of developing cancer starting at a specific age and during a specified number of years.
Return to top
Agespecific rate
The rate of
incidence
or
mortality
of a specific age group, calculated per 100,000 people.
Return to top
Annual Percent Change (APC)
The average annual percent change over several years. The APC is used to measure trends or the change in rates over time. For information on how this is calculated, go to
Trend Algortihms
in the SEER*Stat Help system. The calculation involves fitting a straight line to the natural logarithm of the data when it is displayed by calendar year
Return to top
Cancer Burden
An estimate of the financial, emotional, or social impact that cancer creates within the population. Different racial, ethnic, geographic, and age groups in the United States do not share the burden of disease equally
Return to top
Collaborative Staging Algorithm
A joint effort by several organizations to develop standard computerized methods for determining the stage of cancer based on tumor size, extension of the primary tumor, lymph node involvement, and metastases. This algorithm allows one to obtain both the American Joint Committee on Cancer (AJCC) stage and the
SEER historic stage
. The AJCC stage is used clinically, but its definitions change over time. The definitions of the SEER historic stages have remained constant over time
Go to
AJCC Collaborative Staging
Web site for further information and site specific algorithms
Return to top
Confidence Interval
A range of values that has a specified probability of containing the estimated rate or trend of interest. The 95% (pvalue = 0.05) and 99% (pvalue = 0.01) confidence intervals are the most commonly used.
If an estimated
annual percentage change (APC)
is 2.44 with a 95% confidence interval of (2.83, 2.05), then we are 95% confident that the actual APC is between a decrease of 2.83% and a decrease of 2.05%. Inversely, there is still a 5% chance that the actual APC is not in the confidence interval (between the upper and lower confidence limits)
Return to top
Crude Probability of Death
The crude probability of death measures the mortality patterns actually experienced in a cohort of cancer patients on which many possible causes of death are acting simultaneously
Return to top
Crude Rate
A crude rate is the ratio of the number of people in which the event of interest happens in a specified time period to the size of the population who may experience this event during the same time period. There are no adjustments made when a crude rate is given
Return to top
Death rate
See
Mortality
Return to top
Delayadjusted Incidence
A term related to
incidence
. An algorithm is used to estimate the incidence if it were unaffected by
reporting delays
Return to top
Delayed Reporting
See
Reporting delay
Return to top
Extent of Disease
See
Stage
Return to top
ICCC Classification
At the time the World Health Organization's (WHO) International Agency for Research on Cancer (IARC) published their first monograph on Childhood Cancer in 1988, Dr. R. Marsden published an annex giving a classification scheme for childhood cancer that consisted of 12 groups based chiefly on histologic type. The classification by Marsden has been modified and is now called the
International Classification of Childhood Cancers
.
Return to top
In situ cancer
See
Stage
Return to top
Incidence
The number of newly diagnosed cases of cancer during a specific time period
The American Cancer Society estimated that there would be approximately 1,399,790 people first diagnosed with cancer in 2006.
Return to top
Incidence Rate
The ratio of the number of new cancers of a specific site/type occurring in a specified population during a year to the number of individuals who were at risk for the given cancer, generally expressed as the number of cancers per 100,000 persons
Return to top
Invasive Cancer
Cancer that has spread beyond the layer of tissue in which it developed and is growing into surrounding, healthy tissues  generally, the stage is either "localized", "regional", or "distant".
Return to top
Joinpoint
A statistical model for characterizing cancer trends which uses statistical criteria to determine how many times and when the trends in incidence or mortality rates have changed. The results of joinpoint are given as calendar year ranges, and the annual percent change (APC) in the rates over each period
Return to top
Lifetime Risk
The probability of developing cancer in the course of one's lifespan. Lifetime risk may also be discussed in terms of the probability of developing or of dying from cancer
Based on cancer rates from 2001 to 2003, it was estimated that men had about a 45 percent chance of developing cancer in their lifetimes, while women had about a 38 percent chance
Return to top
Malignant Cancer
See
Invasive cancer
Return to top
Median Age at Diagnosis/Death
The age at which half of all reported cases were older and half were younger
Return to top
Mortality
The number of deaths from cancer during a specific time period
Return to top
Prevalence, Complete
The number of people alive on a certain date who have been diagnosed with cancer at any time in their lives. This is different from incidence in that it considers both newly diagnosed and previously diagnosed people
Return to top
Prevalence, Limited Duration
The number of people who have received a diagnosis of cancer during a defined time period, and who are alive on the last day of that period. Most prevalence data in SEER is for limited duration because information on cases diagnosed before 1973 is not generally available
Return to top
Primary Tumor
An original tumor. A tumor that did not initially arise in another site
Return to top
Probability
The chance that an event occurs. It is usually expressed as a percent. Zero percent denotes impossibility, while 100% denotes certainty
Return to top
Probability of Developing Cancer
The chance that a person will develop cancer in his/her lifetime
Return to top
Probability of Dying of Cancer
The chance that a person will die from cancer
Return to top
Reporting Delay
The time elapsed before a diagnosed cancer case is reported to the NCI.
Currently, there is a standard delay of 22 months between the end of the diagnosis year and the time SEER cancer registries first report cancers to the NCI. Cancers are reported November 1 of each year for all years including the complete year two previous to the current year. However, SEER cancer registries continue to update registry data indefinitely, so statistics may change, becoming more accurate, every year.
Return to top
SEER
The Surveillance, Epidemiology, and End Results (SEER) Program of the NCI is a collection of central cancer registries in the United States that collect and submit cancer incidence, prevalence, mortality, survival, stage at diagnosis data and other statistics to the National Cancer Institute. The National Cancer Act of 1971 mandated the collection, analysis, and dissemination of data useful in the prevention, diagnosis, and treatment of cancer leading to the establishment of the SEER Program
Return to top
SEER Registries
Geographic areas that were selected for inclusion in the SEER Program based on their ability to operate and maintain a high quality populationbased cancer reporting system and for their epidemiologically significant population subgroups. See the
SEER Registries
for more information.
See the
Common Terms
page for the combinations of the SEER Registries commonly used in statistical analyses
Return to top
Stage
Stage provides a measure of disease progression, detailing the degree to which the cancer has advanced. Two methods commonly used to determine stage are AJCC and SEER historic. The AJCC method (see
Collaborative Staging Method
) is more commonly used in the clinical settings, while SEER has standardized and simplified staging to ensure consistent definitions over time
SEER describes cancers in five stages

In situ cancer
is early cancer that is present only in the layer of cells in which it began.

Localized cancer
is cancer that is limited to the organ in which it began, without evidence of spread.

Regional cancer
is cancer that has spread beyond the original (primary) site to nearby lymph nodes or organs and tissues.

Distant cancer
is cancer that has spread from the primary site to distant organs or distant lymph nodes.

Unstaged cancer
is cancer for which there is not enough information to indicate a stage.
Return to top
Stage at Diagnosis
The stage (see item above) that the cancer has progressed to at the time of diagnosis
Return to top
Standard Million Population
A standard million population for a geographic area is a table giving the number of persons in each age group 0, 14, ... , 85+ out of a theoretical cohort of 1,000,000 persons that is distributed by age in the same proportions as the population.
Return to top
Standard Population
A standard population for a geographic area, such as the US or the world, is a table giving the proportions of the population falling into the age groups 0, 14, 59,…, 8084, and 85+.
Return to top
Statistically Significant
Describes a mathematical measure of difference between groups. The difference is said to be statistically significant if it is greater than what might be expected to happen by chance alone 95% of the time. Although statistically significant usually refers to 95% confidence, sometimes other confidence levels such as 99% or 90% are specified
Return to top
Surveillance Data (Cancer)
Data that is used to monitor changes in cancer in a population. Included are measures of cancer incidence, morbidity, survival, prevalence and mortality. Also included are the assessment of genetic predisposition, environmental and behavioral risk factors, screening practices, and the quality of care from prevention through palliation
Return to top
Survival
Survival examines how long after diagnosis people live. Cancer survival is measured in a number of different ways depending on the intended purpose. Several examples of survival statistics are listed below
Return to top
Survival, Causespecific
A measure of net survival that is calculated by using the cause of death listed on death certificates to estimate the proportion of deaths due to cancer
Return to top
Survival, Net
Survival from cancer that is calculated in the absence of other causes of death. It represents a hypothetical situation where the only possible cause of death is cancer. Can be calculated as either
relative survival
or
causespecific
survival
Return to top
Survival, Observed
An estimate of the probability of surviving all causes of death for a specified time interval calculated from the cohort of cancer cases. Observed survival does not consider cause of death, it simply looks at who is alive and who is not. Sometimes referred to as overall survival
Return to top
Survival, Period
A newer method for calculating survival that uses only information from the most recent calendar years available. This method is believed to give a more recent estimate than previouslyused methods and may take newer treatment modalities into account more effectively than other methods.
Return to top
Survival, Relative
A measure of net survival that is calculated by comparing observed (overall) survival with expected survival from a comparable set of people that do not have cancer to measure the excess mortality that is associated with a cancer diagnosis
Return to top